A Global Phase 3 Double-Blind Placebo-Controlled Safety and Efficacy Study of Oral Dimebon [dimebolin] in Patients With Mild-to-Moderate Alzheimer's Disease (CONNECTION).
Phase of Trial: Phase III
Latest Information Update: 03 Oct 2016
At a glance
- Drugs Latrepirdine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacogenomic; Registrational; Therapeutic Use
- Acronyms CONNECTION
- 16 Nov 2011 Additional locations added as reported by European Clinical Trials Database (EudraCT2008-000095-25).
- 14 Jul 2010 Results will be presented at the 2010 International Conference on Alzheimer's Disease (ICAD 2010).
- 14 Jul 2010 Trial design details were presented at the 2010 International Conference on Alzheimer's Disease (ICAD 2010).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History